HCPCS Code Detail Logo

HCPCS Codes Similar to G9704

HCPCS Codes Similar to “G9704” Code.
Ajcc breast cancer stage i: t1 mic or t1a documented

G9832
Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b
Code added date: 20170101
Code effective date: 20170101
A9516
Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries
Code added date: 20030101
Code effective date: 20080101
G8927
Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
Code added date: 20130101
Code effective date: 20170101
G8944
Ajcc melanoma cancer stage 0 through iic melanoma
Code added date: 20130101
Code effective date: 20130101
G9705
Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented
Code added date: 20170101
Code effective date: 20170101
G9831
Ajcc stage at breast cancer diagnosis = ii or iii
Code added date: 20170101
Code effective date: 20170101
M1386
Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period
Code added date: 20250101
Code effective date: 20250101
G9077
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101
G9084
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101
G9086
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101
G9090
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101
G9092
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101
G9096
Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101
G9109
Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Code added date: 20060101
Code effective date: 20070101